ARCHIVES

Olaparib Study Demonstrates No Changes In Overall Survival

This article is from The Cancer Letter archive.

Vol. 35 No. 3 | March 30, 2012

Download PDF Visit The Full Archive

Related Articles

Cancergrams Cost $840 Year For All

December 2, 1977

Study Would Try to Validate EGFR FISH as Predictive Marker for Benefit from Tarceva.

July 13, 2007

Children’s Cancer Research Institute at UT Health Science Center recruits faculty.

December 10, 2004

DCPC Plans Future RFAs, But Most Will Depend n bypass Budget

June 22, 1990

Breast Cancer Working Group Lists Research Needed

July 1, 1988

AACI’s “12 Tasks” Outlined to Board

March 28, 1975